The SGLN Biopharma Leaders Programme is designed to prepare Singaporeans for global leadership roles within the biopharmaceutical industry.
Developed in partnership with the Biopharmaceutical Manufacturers’ Advisory Council (BMAC), this co-created programme brings together senior biopharma manufacturing leaders to collectively shape how Singapore develops and grows its next generation of biopharma leadership talent.
This is part of the SGLN Industry Interest Groups (SIIG) initiative launched by DPM and Minister for Trade & Industry Gan Kim Yong in September 2025.
The Singapore Leaders Network (SGLN) is managed by the Human Capital Leadership Institute (HCLI) and supported by the Singapore Economic Development Board (EDB). BMAC is an initiative by leading biopharmaceutical companies in the world to establish Singapore as the country of choice for global biopharma manufacturing.
On 8 September 2025, the Singapore Leaders Network (SGLN) celebrated its third anniversary, marked by the official launch of the SGLN Industry Interest Groups (SIIG) by Deputy Prime Minister and Minister for Trade and Industry Mr Gan Kim Yong. The launch highlighted the national effort to strengthen Singapore’s leadership pipeline in key industries such as biopharmaceutical manufacturing, energy, and chemicals. In his address, DPM Gan underscored the importance of overseas exposure for Singaporean leaders, noting that even firms based locally must be equipped to collaborate and compete globally.
Excerpt from The Straits Times, 8 September 2025
SGLN-BMAC Collaboration
The SGLN Biopharma Leaders Programme builds on the Biopharmaceutical Manufacturers’ Advisory Council’s (BMAC) pioneering groundwork and aligns with SGLN’s mission to prepare Singaporeans for global leadership roles in the biopharmaceutical industry. Through this partnership, SGLN and BMAC embarked on a co-creation journey — shaping a programme designed for the industry, by the industry.
Who is it for?
Singapore Citizens and PRs with 10 or more years of experience — high-potential leaders already trusted to deliver, and now ready to step into regional or global leadership roles within the next 5 years. These are our next-generation site heads, functional leads, and ecosystem connectors.
Three Components
Leadership Modules
Leadership development journey, comprising a local leadership module and a global expedition
Communities of Practice (CoPs)
Cross-company projects tackling industry challenges and shaping its future
Industry Networking & Learning Events
Platform to share insights, spark ideas, and explore the future of Biopharma Manufacturing
Learning Outcomes
Thrive in a complex and ambiguous environment:
Build executive presence, influence, and sponsorship to lead with clarity and confidence across boundaries
Create and leverage strategic networks, and communicate with clarity and authenticity for impact:
Strengthen collaboration across the biopharma ecosystem through strategic networks and peer exchange
Demonstrate cultural flexibility for inclusive leadership:
Develop cross-market fluency and cultural agility through global immersions and experiences
Gain new perspectives, mindsets, and inner motivation to courageously step outside the comfort zone:
Apply learning through outcome-driven projects that address real industry challenges
Learn global best practices across industries and develop ecosystem thinking:
Gain knowledge of leading practices in the world and develop the mindset to see connections and interdependencies that drive sustainable long-term impact